Janpix's Unattributed VC Round

Janpix raised a round of funding on October 12, 2017. Investors include Medicxi Ventures.

Janpix is developing inhibitors of STAT3/5 signaling to treat hematological tumors & GBM.…

Articles about Janpix's Unattributed VC Round: